From Verily Life Sciences, South San Francisco, California.
Circulation. 2021 May 11;143(19):1831-1834. doi: 10.1161/CIRCULATIONAHA.121.053461. Epub 2021 Apr 6.
During the past year, clinicians and the public have been focused on the coronavirus disease 2019 (COVID-19) pandemic and its associated societal and economic effects. However, once the acute phase of this crisis has passed, we will face an enormous wave of death and disability as a result of common chronic diseases (CCDs), with cardiometabolic diseases at the crest (Figure). A tsunami results when an earthquake on the ocean floor creates huge waves that can wreak devastation far distant from the original upheaval, especially when warnings are ignored. Similarly, underlying global and national demographic and risk factor profiles have for some time presaged an overwhelming burden of CCDs. However, although the pandemic has created additional impetus that unless heeded will amplify the consequences of this burden, the rapid adaptations and innovations in care and research prompted by the urgent response to it may also offer us the means to stem this flood.
在过去的一年里,临床医生和公众一直关注 2019 年冠状病毒病(COVID-19)大流行及其带来的社会和经济影响。然而,一旦这场危机的急性期过去,我们将面临因常见慢性病(CCDs)而导致的大量死亡和残疾,其中心血管代谢疾病首当其冲(图)。海啸是由海底地震产生的巨浪引起的,这些巨浪可能在远离最初动荡的地方造成破坏,尤其是在人们忽视警报的情况下。同样,全球和国家的人口和危险因素概况长期以来预示着 CCD 负担将不堪重负。然而,尽管大流行带来了额外的推动力,如果不加以重视,将加剧这一负担的后果,但对其紧急应对所带来的医疗和研究方面的迅速调整和创新,也为我们提供了遏制这场洪灾的手段。